You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Guidelines & Advice

About Guidelines Email Guidelines Team

Displaying Guidelines

235 Items

18-Fluorodeoxyglucose Positron Emission Tomography in the Diagnosis and Staging of Lung Cancer

Document Status: Current
ID: 7-20 Version 2
Version: 2

Oct 2012

18F-FET PET Imaging in Brain Tumours

Document Status: Current
ID: ES PET 20

Apr 2022

2019 Antiemetic Recommendations for Chemotherapy-Induced Nausea and Vomiting: A Clinical Practice Guideline

Document Status: Current
ID: GL-C50-09

Jun 2019

Acute Leukemia Provincial Plan

Document Status: Current
ID: GL-C50-34

Aug 2017

Adjuvant Care for Stage I Ovarian Cancer

Document Status: Current
ID: 4-13
Version: 3

Mar 2022

Adjuvant Systemic Chemotherapy for Stage II and III Colon Cancer Following Complete Resection

Document Status: Current
ID: 2-29
Version: 4

Feb 2024

Adult Acute Leukemia Services Plan for the Greater Toronto Area - Recommendations Report

Document Status: Current
ID: GL-C50-02

Jan 2012

Adult Sarcoma Management in Ontario

Document Status: Current
ID: GL-C50-04-V2
Version: 2

Jan 2009

An Endorsement of the 2021 Cancer Care Alberta Clinical Practice Guideline on Uveal Melanoma

Document Status: Current
ID: C50-CIDAP-1

Mar 2024

An Endorsement of the 2021 Guideline on Chemotherapy in Combination with Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline

Document Status: Current
ID: GL END 5-7
Version: 3

Nov 2021

An Endorsement of the 2022 NCCN Guideline on Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)

Document Status: Current
ID: GL-END-C50-35

Aug 2023

An Endorsement of the 2023 European Association of Urology (EAU) -American Society of Clinical Oncology (ASCO) Guidelines on Penile Cancer

Document Status: Current
ID: Guideline Endorsement C50-CIDAP-2

Nov 2024